Does oral vancomycin prophylaxis during systemic antibiotic exposure prevent Clostridioides difficile infection relapses? Still in search of an answer
Infect Control Hosp Epidemiol
.
2019 Sep;40(9):1084-1086.
doi: 10.1017/ice.2019.192.
Epub 2019 Jul 10.
Authors
Jeannie D Chan
1
,
Chloe Bryson-Cahn
2
,
Rupali Jain
3
,
John B Lynch
2
,
Catherine Liu
2
Affiliations
1
Department of Pharmacy,Harborview Medical Center,Seattle, Washington.
2
Department of Medicine, Division of Allergy and Infectious Diseases, School of Medicine,University of Washington,Seattle, Washington.
3
School of Pharmacy,University of Washington,Seattle, Washington.
PMID:
31288875
DOI:
10.1017/ice.2019.192
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Clostridioides difficile*
Clostridium Infections*
Humans
Recurrence
Vancomycin
Substances
Anti-Bacterial Agents
Vancomycin